| __timestamp | ACADIA Pharmaceuticals Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 10811000 |
| Thursday, January 1, 2015 | 90804000 | 33001000 |
| Friday, January 1, 2016 | 186456000 | 64936000 |
| Sunday, January 1, 2017 | 255062000 | 99909000 |
| Monday, January 1, 2018 | 265758000 | 127724000 |
| Tuesday, January 1, 2019 | 325638000 | 161524000 |
| Wednesday, January 1, 2020 | 388661000 | 182933000 |
| Friday, January 1, 2021 | 396028000 | 219982000 |
| Saturday, January 1, 2022 | 369090000 | 278139000 |
| Sunday, January 1, 2023 | 402466000 | 309799000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, understanding the financial strategies of key players is crucial. Over the past decade, ACADIA Pharmaceuticals Inc. and Ultragenyx Pharmaceutical Inc. have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking in 2023. This reflects a strategic investment in marketing and administrative capabilities, crucial for their growth and market penetration. In contrast, Ultragenyx's expenses grew by approximately 2,800% during the same period, indicating a robust expansion strategy. Notably, both companies experienced their highest expense growth between 2020 and 2023, a period marked by global challenges and opportunities in the healthcare sector. These trends highlight the dynamic nature of the pharmaceutical industry and the strategic financial decisions that drive success.
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Ultragenyx Pharmaceutical Inc.
Who Optimizes SG&A Costs Better? Regeneron Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Ultragenyx Pharmaceutical Inc.
Selling, General, and Administrative Costs: Viatris Inc. vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
Alkermes plc or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends